This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kocisko, D. A.
Right arrow Articles by Morrey, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kocisko, D. A.
Right arrow Articles by Morrey, J. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2006, p. 759-761, Vol. 50, No. 2
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.2.759-761.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

A Porphyrin Increases Survival Time of Mice after Intracerebral Prion Infection

David A. Kocisko,1* Winslow S. Caughey,1 Richard E. Race,1 Grant Roper,2 Byron Caughey,1 and John D. Morrey2

Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana,1 Institute for Antiviral Research, Animal, Dairy, and Veterinary Sciences Department, Utah State University, Logan, Utah2

Received 8 September 2005/ Returned for modification 14 November 2005/ Accepted 23 November 2005

Prion diseases, including scrapie, are incurable neurodegenerative disorders. Some compounds can delay disease after a peripheral scrapie inoculation, but few are effective against advanced disease. Here, we tested multiple related porphyrins, but only Fe(III)meso-tetra(4-sulfonatophenyl)porphine injected into mouse brains after intracerebral scrapie inoculation substantially increased survival times.


* Corresponding author. Mailing address: Rocky Mountain Laboratories, 903 S. 4th Street, Hamilton, MT 59840. Phone: (406) 375-9692. Fax: (406) 363-9286. E-mail: DKocisko{at}niaid.nih.gov.


Antimicrobial Agents and Chemotherapy, February 2006, p. 759-761, Vol. 50, No. 2
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.2.759-761.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Song, C.-H., Honmou, O., Ohsawa, N., Nakamura, K., Hamada, H., Furuoka, H., Hasebe, R., Horiuchi, M. (2009). Effect of Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells on Mice Infected with Prions. J. Virol. 83: 5918-5927 [Abstract] [Full Text]  
  • Song, C.-H., Furuoka, H., Kim, C.-L., Ogino, M., Suzuki, A., Hasebe, R., Horiuchi, M. (2008). Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice. J. Gen. Virol. 89: 1533-1544 [Abstract] [Full Text]  
  • Lee, K. S., Raymond, L. D., Schoen, B., Raymond, G. J., Kett, L., Moore, R. A., Johnson, L. M., Taubner, L., Speare, J. O., Onwubiko, H. A., Baron, G. S., Caughey, W. S., Caughey, B. (2007). Hemin Interactions and Alterations of the Subcellular Localization of Prion Protein. J. Biol. Chem. 282: 36525-36533 [Abstract] [Full Text]  
  • Caughey, W. S., Priola, S. A., Kocisko, D. A., Raymond, L. D., Ward, A., Caughey, B. (2007). Cyclic Tetrapyrrole Sulfonation, Metals, and Oligomerization in Antiprion Activity. Antimicrob. Agents Chemother. 51: 3887-3894 [Abstract] [Full Text]  
  • Doh-ura, K., Kuge, T., Uomoto, M., Nishizawa, K., Kawasaki, Y., Iha, M. (2007). Prophylactic Effect of Dietary Seaweed Fucoidan against Enteral Prion Infection. Antimicrob. Agents Chemother. 51: 2274-2277 [Abstract] [Full Text]  
  • Trevitt, C. R, Collinge, J. (2006). A systematic review of prion therapeutics in experimental models. Brain 129: 2241-2265 [Abstract] [Full Text]